Peter Flanagan
Impact in
- Biochemistry top 10%
- Blood transfusion and management
- Hepatology top 10%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
Papers in
-
- Blood groups and transfusion 5
- Platelet Disorders and Treatments 2
-
- Hepatitis B Virus Studies 4
- Co-authors
- Richard Charlewood (4 shared papers)Mary J. Berry (2 shared papers)T. R. O. Beringer (1 shared paper)J. A. J. Barbara (1 shared paper)Katya Ruggiero (1 shared paper)David Harte (1 shared paper)M. W. Sutherland (1 shared paper)Yann Echelard (1 shared paper)
- Journals
- Vox Sanguinis (6 papers)Transfusion (3 papers)British Journal of Haematology (1 paper)Journal of Clinical Pathology (1 paper)Haemophilia (1 paper)
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
Peter Flanagan
35 papers receiving 286 citations
Peers
Comparison fields: 5 of 56
- Biochemistry 45
- Hepatology 51
- Management of Technology and Innovation 43
- Hematology 48
- Infectious Diseases 37
Countries citing papers authored by Peter Flanagan
This map shows the geographic impact of Peter Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Flanagan more than expected).
Fields of papers citing papers by Peter Flanagan
This network shows the impact of papers produced by Peter Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Flanagan. The network helps show where Peter Flanagan may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Flanagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 35 | |
| 2 | 2019 | 33 | |
| 3 | 2012 | 28 | |
| 4 | 1988 | 20 | |
| 5 | Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors. | 2018 | 18 |
| 6 | 2013 | 16 | |
| 7 | 2016 | 15 | |
| 8 | 1995 | 15 | |
| 9 | Acute medical bed usage by nursing home residents. | 1999 | 14 |
| 10 | 1998 | 14 | |
| 11 | 1999 | 12 | |
| 12 | 1995 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2011 | 8 | |
| 15 | 2017 | 7 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 4 | |
| 18 | 2012 | 4 | |
| 19 | 1993 | 4 | |
| 20 | 1989 | 4 |
About Peter Flanagan
Peter Flanagan is a scholar working on Hematology, Epidemiology, Management of Technology and Innovation, Biochemistry and Hepatology, having authored 36 papers that have together received 309 indexed citations. Recurring topics across this work include Blood transfusion and management (7 papers), Blood donation and transfusion practices (7 papers), Blood groups and transfusion (5 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Organ Donation and Transplantation (4 papers), Parasitic Infections and Diagnostics (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Biochemistry (45 citations), Hepatology (51 citations), Management of Technology and Innovation (43 citations), Hematology (48 citations) and Infectious Diseases (37 citations). Peter Flanagan has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Richard Charlewood, Mary J. Berry, T. R. O. Beringer, J. A. J. Barbara, Katya Ruggiero, David Harte, M. W. Sutherland, Yann Echelard, Jennifer L. Williams and Joanne Hewitt. Their work appears in journals such as Vox Sanguinis, Transfusion, British Journal of Haematology, Journal of Clinical Pathology and Haemophilia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.